Vir Biotechnology
VIR
VIR
119 hedge funds and large institutions have $2.41B invested in Vir Biotechnology in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 22 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 112 → 119 (+7)
2% more call options, than puts
Call options by funds: $5.68M | Put options by funds: $5.6M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
119
Holding in Top 10
3
Calls
$5.68M
Puts
$5.6M
Top Buyers
| 1 | +$350M | |
| 2 | +$178M | |
| 3 | +$18M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$15M |
| 5 |
Goldman Sachs
New York
|
+$11.2M |
Top Sellers
| 1 | -$38.9M | |
| 2 | -$25.4M | |
| 3 | -$5.96M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.22M |